These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3024987)

  • 1. Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.
    Fraher LJ; Karmali R; Hinde FR; Hendy GN; Jani H; Nicholson L; Grant D; O'Riordan JL
    Eur J Pediatr; 1986 Oct; 145(5):389-95. PubMed ID: 3024987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
    Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
    J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
    Griffin JE; Zerwekh JE
    J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.
    Takeda E; Yokota I; Kawakami I; Hashimoto T; Kuroda Y; Arase S
    Eur J Pediatr; 1989 Oct; 149(1):54-7. PubMed ID: 2558018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
    Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
    J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.
    Feldman D; Chen T; Cone C; Hirst M; Shani S; Benderli A; Hochberg Z
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1020-2. PubMed ID: 6288751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
    Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
    Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
    Adams JS; Gacad MA; Singer FR
    J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
    Malloy PJ; Hochberg Z; Pike JW; Feldman D
    J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
    Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
    J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol-resistant rickets with alopecia.
    Hochberg Z; Gilhar A; Haim S; Friedman-Birnbaum R; Levy J; Benderly A
    Arch Dermatol; 1985 May; 121(5):646-7. PubMed ID: 2986561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
    Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
    J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
    Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
    J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
    Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
    Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
    Hirst MA; Hochman HI; Feldman D
    J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
    Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
    J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.